Formulation development and pharmacological evaluation of fixed dose combination of Bombyx mori coccon shell extract, Flaxseed oil and coenzyme Q10 against doxorubicin induced cardiomyopathy in rats

  • Mohammad Tarique
  • BadruddeenEmail author
  • Farogh Ahsan
  • Juber Akhtar
  • Mohammad Irfan Khan
  • Mohammad Khalid
Research Article


The present study aims at formulation development and pharmacological evaluation of fixed dose combination of Bombyx mori (Abresham) extract, Flaxseed oil and coenzyme Q10 (CoQ10) against doxorubicin induced myocardial toxicity in rats. Formulation (emulsion) was prepared using dry gum method (continental method), by using pestle and mortar. The formulation was characterized by performing stability studies which includes flocculation and creaming, cracking, phase inversion and accelerated studies (temperature and light). In-vivo pharmacological evaluation of Bombyx mori coccon shell extract, Flaxseed oil, CoQ10 and its fixed dose combination (FDC) were then performed. Results obtained indicates that developed FDC and extract, Oil, CoQ10 passed all stability tests and significantly prevented drug induced increase in serum levels of AST, ALT, LDH, Creatinine and lipid profile (TC, LDL, VLDL and TG) and increases the levels of HDL and antioxidant parameters—SOD, GSH and CAT (in heart tissue). It also lowered the doxorubicin induced increase in heart weight due to hypertrophy. These results were also confirmed by histopathology. The results of this study strongly indicate the cardioprotective effect of fixed dose combination of BME, Flaxseed oil and CoQ10 against doxorubicin induced myocardial toxicity.


Bombyx mori Coenzyme Q10 Doxorubicin Flaxseed oil Myocardial infarction Cardiomyopathy 



Author thanks Prof. Syed Waseem Akhtar, Hon. Chancellor and Prof. Aqil Ahmad, Hon. Vice Chancellor for providing excellent research facility in the university. The university has provided a manuscript communication number for further communication (IU/R&D/2018-MCN000507).

Compliance with ethical standards

Ethical statement

The study protocols was approved by Institutional Animal Ethical Committee (IAEC), Faculty of Pharmacy, Integral University, Lucknow (Reg No. 1213/PO/Re/S/08/CPCSEA, 5th June 2008) having Approval No. IU/IAEC/18/17.

Conflict of interest

This manuscript described has not been published before; not under consideration for publication anywhere else; and has been approved by all co-authors.


  1. Ahsan F, Ansari TM, Usmani S, Bagga P (2018) An insight on silk protein sericin: from processing to biomedical application. Drug Res (Stuttg) 68:317–327. CrossRefGoogle Scholar
  2. Akhtar S, Anjum FM, Rehman SU et al (2008) Effect of fortification on physico-chemical and microbiological stability of whole wheat flour. Food Chem 110:113–119. CrossRefGoogle Scholar
  3. Ayaz SA, Bhandari U, Pillai KK (2005) Influence of DL α-lipoic acid and vitamin-E against doxorubicin-induced biochemical and histological changes in the cardiac tissue of rats. Indian J Pharmacol 37:294–299CrossRefGoogle Scholar
  4. Bonsnes WR, Taussky HH (1945) Determination of creatinine in plasma and urine. J Biochem 58:581–590. Google Scholar
  5. Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583–595Google Scholar
  6. Dhalla NS, Elmoselhi AB, Hata T, Makino N (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47:446–456. CrossRefGoogle Scholar
  7. Dorairaj Jeemon P, Sharma M et al (2018) The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Heal 6:e1339–e1351. CrossRefGoogle Scholar
  8. Ferrari R, Alfieri O, Curello S et al (1990) Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81:201–211. CrossRefGoogle Scholar
  9. Firoz M, Bharatesh K, Nilesh P et al (2011) Cardioprotective activity of ethanolic extract of Callistemon lanceolatus leaves on doxorubicin-induced cardiomyopathy in rats. Bangladesh J Pharmacol 6:38–45. CrossRefGoogle Scholar
  10. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502Google Scholar
  11. Fu X, Ji R, Dam J (2009) Acute, subacute toxicity and genotoxic effect of Bio-Quinone® Q10 in mice and rats. Regul Toxicol Pharmacol 53:1–5. CrossRefGoogle Scholar
  12. Greenlee H, Shaw J, Lau YKI et al (2012) Lack of effect of coenzyme Q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integr Cancer Ther 11:243–250. CrossRefGoogle Scholar
  13. Gupta R, Gupta VP (1998) Lessons for prevention from a coronary heart disease epidemiological study in western India. Curr Sci 74:1074–1077Google Scholar
  14. Jain K, Sharma N (2008) A text book of professional pharmacy, biphasic liquid dosage form. Vallabh Prakashan, New DelhiGoogle Scholar
  15. James K (1965) The dehydrogenases or oxidoreductases—lactate dehydrogenase. Van Nostrand, LondonGoogle Scholar
  16. Kaithwas G, Mukherjee A, Chaurasia AK, Majumdar DK (2011) Antiinflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil. Indian J Exp Biol 49:932–938Google Scholar
  17. Krishnaswami S (1998) Observations on serial changes in coronary artery disease in Indians. Curr Sci 74:1064–1068Google Scholar
  18. Lopez AD, Murray CCL (1998) The global burden of disease, 1990–2020. Nat Med 4:1241–1243. CrossRefGoogle Scholar
  19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275. Google Scholar
  20. Ma X, Ding Y, Wang Y, Xu X (2018) A doxorubicin-induced cardiomyopathy model in adult Zebrafish. J Vis Exp 136:e57567. Google Scholar
  21. Mahmood ZA, Sualeh M, Mahmood SBZ, Karim MA (2010) Herbal treatment for cardiovascular disease the evidence based therapy. Pak J Pharm Sci 23:119–124Google Scholar
  22. Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175Google Scholar
  23. Mohan M, Patankar P, Ghadi P, Kasture S (2010) Cardioprotective potential of Punica granatum extract in isoproterenol-induced myocardial infarction in Wistar rats. J Pharmacol Pharmacother 1:32–37. CrossRefGoogle Scholar
  24. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. BBA Gen Subj 582:67–78. CrossRefGoogle Scholar
  25. Parekh AC, Jung DH (1970) Cholesterol determination with ferric acetate-uranium acetate and sulfuric acid-ferrous sulfate reagents. Anal Chem 42:1423–1427. CrossRefGoogle Scholar
  26. Rattana S, Katisart T, Sungthong B, Butiman C (2017) Acute and sub-acute toxicities of thai silkworm powder (Bombyx mori Linn.) from three races in male Wistar rats and in vitro antioxidant activities. Pharmacogn J 9:541–545. CrossRefGoogle Scholar
  27. Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:104–110CrossRefGoogle Scholar
  28. Rice EW, Epstein MB, RoF Witter, Platt Herbert A (1970) Triglycerides (“Neutral Fat”) In Serum *. Stand Methods Clin Chem 6:215–222CrossRefGoogle Scholar
  29. Rona G, Chappel C, Balazs T, Gaudry R (1959) An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67:443–455Google Scholar
  30. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205. CrossRefGoogle Scholar
  31. Singh S, Majumdar DK (1997) Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil. Indian J Exp Biol 35:380–383. Google Scholar
  32. Singh Ram B, Gurpreet SW, Rastogi A et al (1998) Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther 10:347–353CrossRefGoogle Scholar
  33. Singh KK, Mridula D, Rehal J, Barnwal P (2011) Flaxseed: a potential source of food, feed and fiber. Crit Rev Food Sci Nutr 51:210–222. CrossRefGoogle Scholar
  34. Sinha BK, Katki AG, Batist G et al (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36:793–796. CrossRefGoogle Scholar
  35. Subhashini N, Nagaranjan G (2011) Cardioprotective effect of Garcinia cambogia an iso-induced myocardial infarction in albino rats. Pharm Prof 1:91–100Google Scholar
  36. Takahara BS, Hamilton HB, Neel JV et al (1960) Hypocatalasemia: a new genetic carrier state. J Clin Invest 39:610–619. CrossRefGoogle Scholar
  37. Togo T (2017) Cell membrane disruption stimulates cAMP and Ca2+ signaling to potentiate cell membrane resealing in neighboring cells. Biol Open 6:1814–1819. CrossRefGoogle Scholar
  38. Vennila L, Pugalendi KV (2010) Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep Commun Free Radic Res 15:36–42. CrossRefGoogle Scholar

Copyright information

© Institute of Korean Medicine, Kyung Hee University 2019

Authors and Affiliations

  • Mohammad Tarique
    • 1
  • Badruddeen
    • 1
    Email author
  • Farogh Ahsan
    • 1
  • Juber Akhtar
    • 1
  • Mohammad Irfan Khan
    • 1
  • Mohammad Khalid
    • 1
  1. 1.Faculty of PharmacyIntegral UniversityLucknowIndia

Personalised recommendations